Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowHancock County-based agbioscience startup Verility Inc. has closed a $3.5 million Series A funding round that will allow it to commercialize its animal fertility platform, the company announced Wednesday.
The round was led by Mountain Group Partners of Nashville, Tennessee, and includes a previous investment from Purdue Foundry.
The technology, Fertile-Eyez, analyzes swine fertility, enabling livestock producers to accelerate reproduction among the herd.
The Maxwell-based ag tech company said the system provides livestock breeders simple and cost-effective analysis to predict ovulation phase and sperm quality.
“It’s extremely exciting to have the ability to bring automated mobile breeding technologies into a segment of the animal health industry that normally does not see much innovation,” said Verility co-founder and CEO Liane Hart.
Hart said improving sperm analysis and improving ovulation detection for animal breeding are two of the most important ways to meet the critical need for more edible meat protein.
The company has licensed the intellectual property from Boston-based Brigham and Women’s Hospital, a not-for-profit teaching affiliate of Harvard Medical School, where it. A research team from the school was originally created and validated its use in humans.
“The proprietary, AI-enabled, smartphone-based platform technology that my lab has created has broad applications in precision animal health and breeding,” said Professor Hadi Shafiee, a faculty member at the institution, in written comments. “This Series A funding will help us to commercialize our first AI-enabled product for accurate, affordable and real-time ovulation prediction in swine.”
Hart says she expects commercialization in late 2023.
Verility was one of two winners of the Purdue Ag-Celerator program in January and received $100,000 from the agriculture innovation fund.
Please enable JavaScript to view this content.